Literature DB >> 17868052

Pathways to discovery in epilepsy research: rethinking the quest for cures.

Daniel H Lowenstein1.   

Abstract

This paper, based on the 4th Annual Hoyer Lecture presented at the 2006 annual meeting of the American Epilepsy Society, first provides a general view of the current limitations in therapies aimed at achieving the goal of "no seizures, no side effects" for patients living with epilepsy. Some of the seminal discoveries in epilepsy research over the past 100 years are then reviewed, with an emphasis on the pivotal role of basic and clinical/translational science in leading the way to new and effective means for diagnosing and treating for epilepsy. The paper concludes with a view of the future course of epilepsy research. Scientific advances will increasingly rely on the collaboration of multidisciplinary teams of researchers using the analytic and storage capabilities of machines, and linked together by communication tools such as the Internet and related technologies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868052     DOI: 10.1111/j.1528-1167.2007.01309.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  1 in total

1.  Saikosaponin a mediates the anticonvulsant properties in the HNC models of AE and SE by inhibiting NMDA receptor current and persistent sodium current.

Authors:  Yun-Hong Yu; Wei Xie; Yong Bao; Hui-Ming Li; San-Jue Hu; Jun-Ling Xing
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.